City
Epaper

New Zealand approves Pfizer/BioNTech vaccine, expects 1st batch by April

By ANI | Updated: February 3, 2021 18:46 IST

New Zealand authorised emergency use of the Pfizer/BioNTech coronavirus vaccine on Wednesday, with a view to receiving the first shipment by April.

Open in App

New Zealand authorised emergency use of the Pfizer/BioNTech coronavirus vaccine on Wednesday, with a view to receiving the first shipment by April.

It is the first COVID-19 vaccine to be approved in the country.

"Medsafe's [regulator's] decision is the culmination of a rigorous assessment process over many months to ensure the Pfizer/BioNTech vaccine is safe and effective to use here. It is informed by the most up to date medical and scientific data. We can have confidence in their decision," Prime Minister Jacinda Ardern said, as quoted in a press release.

Frontline medical workers, border staff and risk groups will be the first in line to receive the shots.

"We expect the first Pfizer/BioNTech vaccines will arrive in New Zealand by the end of the first quarter, but we are making sure everything is in place in case there is an earlier arrival," COVID-19 Response Minister Chris Hipkins stated.

According to national media, the country will first receive 450,000 out of 1.5 million Pfizer vaccine doses. The island nation also has contracts with other vaccine manufacturers -- Janssen, AstraZeneca and Novovax. (/Sputnik)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Jacinda ArdernAstrazenecaChris hipkinsAstrazeneca plc.
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalExperts reckon holding inclusive election would honour former Bangladesh PM Khaleda Zia's legacy

InternationalToo early to compare Khaleda Zia legacy with Tarique Rahman’s future India-stand

InternationalUAE issues statement on ongoing developments in Yemen

InternationalConcerns mount with China’s wargames around Taiwan after US pledges huge arms sale

InternationalUS-led strikes net 25 ISIS operatives in Syria